Episode 3 - Exploring Private Markets Through a Self-Directed IRA Ft. Astrocyte
From The Alternative Investing Angle · 30:32
Show by Madison Trust Company
Join Madison Trust for an educational conversation with William S. Korinek, Ph.D., Co-Founder and CEO of Astrocyte Pharmaceuticals, as he discusses the science and clinical research behind the company’s work in concussion, traumatic brain injury, and stroke. We’ll also explore the role Self-Directed IRAs can play in holding alternative assets, while providing an educational look at private companies, and clinical-stage drug development.
More episodes of The Alternative Investing Angle
More episodes
- Episode 10 - Understanding the Student Housing Real Estate Market Ft. Rise Select
- Episode 9 - Exploring Private Credit Investments with a Self-Directed IRA Ft. Mid Atlantic
- Episode 8 - Inside The Gray Pine's Group Investment Process (Ft. The Gray Pine Group)
- Episode 7 - Your Account, Your Direction: Navigating Your Account
- Episode 6 - Behind the AI Revolution: Investing in Energy with a Self-Directed IRA ft. AI Energy Investors
- Episode 5 - Before the IPO: Understanding Private Market Investing with a Self-Directed IRA ft Nuvion Ventures
- Episode 4 - The Self-Directed Roth IRA: Unlocking Alternative Investments with Tax-Advantages
- Episode 0 - Alternative Investing Angle Podcast Channel Trailer
- Episode 1 - Money Matters: Exploring Tax-Advantaged Retirement Planning Strategies Ft. Keith Blackborg, CPA
- Episode 2 - Understanding Potential Risk Factors in a Retirement Account Ft. Rembrandt Capital
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.